Half-Million patient liver disease study launches

NCT ID NCT05744713

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Target PharmaSolutions, Inc. Source: ClinicalTrials.gov ↗

Summary

This study aims to better understand chronic liver disease and cirrhosis by tracking the health journeys of 500,000 patients over time. Researchers will observe how the disease naturally progresses and how different treatments work in real-world settings. The study collects medical records and patient surveys but does not test new treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Atrium Health Center for Liver Disease and Transplant

Charlotte, North Carolina, 28204, United States
Baylor College of Medicine

Houston, Texas, 77021, United States
Baylor Scott & White Research Institute

Dallas, Texas, 75246, United States
Columbia University Irving Medical Center/ New York Presbyterian Hospital

New York, New York, 10032, United States
Georgetown Medstar Transplant Institute

Washington D.C., District of Columbia, 20007, United States
Keck School of Medicine of USC

Los Angeles, California, 90033, United States
Rush University Medical Center

Chicago, Illinois, 60612, United States
Stanford Medicine

Redwood City, California, 94063, United States
Temple University - Lewis Katz School of Medicine

Philadelphia, Pennsylvania, 19140, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Conditions

Explore the condition pages connected to this study.

CHRONIC LIVER DISEASE CIRRHOSIS